{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-058626","form_type":"8-K","ticker":null,"cik":"0000811240","company_name":"BIOLASE, INC","filed_at":"2024-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.038199+00:00","generated_at":"2026-06-02T03:01:38.701586+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"BIOLASE Q1 net revenue $10.1M (down 3% YoY); reiterates FY2024 guidance","bullets":["Net revenue $10.1M, down 3% YoY; U.S. laser revenue down 22% to $2.7M.","Gross margin improved to 33% (up 1 ppt YoY); operating loss narrowed 15% to $4.5M.","Consumables revenue up 14% YoY; third strongest consumables quarter in company history.","Adjusted EBITDA loss improved 21% to $3.5M ($0.20 per share) vs. $4.4M a year ago.","Reaffirms FY2024 guidance: revenue $52-53M (6-8% growth) and positive Adjusted EBITDA."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-058626","json":"https://secwatch.observer/filing/0000950170-24-058626.json","markdown":"https://secwatch.observer/filing/0000950170-24-058626.md","text":"https://secwatch.observer/filing/0000950170-24-058626.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/811240/000095017024058626/0000950170-24-058626-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/811240/000095017024058626/biol-20240513.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T03:01:38.701586+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"340a97fd22a9d44a76df48bfd825acf2471fd3f3","claim":"BIOLASE, INC reported first quarter ended March 31, 2024 results: revenue $10.1 million. Guidance reaffirmed.","evidence_excerpt":"resources necessary to maximize our growth opportunities and to enhance shareholder value.” First Quarter Financial Results Net revenue for the quarter ended March 31, 2024, was $10.1 million, a decrease of 3% compared to net revenue of $10.5 million for the quarter ended March 31, 2023. U.S. laser revenue was $2.7 million for the quarter ended March 31, 2024, a","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/811240/000095017024058626/0000950170-24-058626-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Revenue","value":"$10.1 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}